Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 31, 2005 - Issue 4-5
Submit an article Journal homepage
106
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Competitive Displacement of Clozapine from Plasma Proteins in Normolipidemic and Hyperlipidemic Plasma Samples: Clinical Implications

Dr. Ric M. Procyshyn Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada; Division of Medical Services, Riverview Hospital, Port Coquitlam, British Columbia, Canada
, Ph.D.,
Tiffany Ho Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada
&
Kishor M. Wasan Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada
, Ph.D.
Pages 331-337 | Published online: 26 Sep 2008

References

  • Brunner L. J., Vadie, K., & Luke, D. R. (1988). Cyclosporine disposition in the hyperlipidemic rat model. Research Communications in Chemical Pathology and Pharmacology, 59, 339–348., [PUBMED], [INFOTRIEVE]
  • Diebold, K., Michel, G., Schweizer, J., Diebold-Dorsam, M., Fiehn, W., & Kohl, B. (1998). Are psychoactive drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders? Pharmacopsychiatry, 31, 60–67., [PUBMED], [INFOTRIEVE], [CSA]
  • Dursun, S. M., Szemis, A., Andrews, H., & Reveley, M. A. (1999). The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study. Journal of Psychiatry and Neuroscience, 24, 453–455., [PUBMED], [INFOTRIEVE], [CSA]
  • Gaulin, B. D., Markowitz, J. S., Caley, C. F., Nesbitt, L. A., & Dufresne, R. L. (1999). Clozapine-associated elevation in serum triglycerides. American Journal of Psychiatry, 156, 1270–1272., [PUBMED], [INFOTRIEVE]
  • Ghaeli, P., & Dufresne, R. L. (1996). Serum triglyceride levels in patients treated with clozapine. American Journal of Health System Pharmacy, 53, 2079–2081., [PUBMED], [INFOTRIEVE]
  • Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000). Clozapine diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. American Journal of Psychiatry, 157, 975–981., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Koch-Weser, J., & Sellers, E. M. (1976). Binding of drugs to serum albumin. New England Journal of Medicine, 294, 311–316., [PUBMED], [INFOTRIEVE]
  • Leadbetter, R., Shutty, M., Pavalonis, D., et al. (1992). Clozapine-induced weight gain: prevalence and clinical relevance. American Journal of Psychiatry, 149, 68–72., [PUBMED], [INFOTRIEVE]
  • Lemaire, M., & Tillement, J. P. (1982). Rose of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporine A in the blood. Journal of Pharmacy and Pharmacology, 34, 715–718., [PUBMED], [INFOTRIEVE]
  • Pande, S., Procyshyn, R. M., Nazerali, M., Attwood, D., & Chow, K. (2002). Do triglycerides modulate the effectiveness of clozapine? International Clinical Psychopharmacology, 17, 197–199., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Procyshyn, R. M., Kennedy, N. B., Marriage, S., & Wasan, K. M. (2001). Plasma protein and lipoprotein distribution of clozapine. American Journal of Psychiatry, 158, 949–951., [PUBMED], [INFOTRIEVE]
  • Spivak, B., Lamschtein, C., Talmon, Y., Guy, N., Mester, R., Feinberg, I., Kotler, M., & Weizman, A. (1999). The impact of clozapine treatment on serum lipids in chronic schizophrenic patients. Clinical Neuropharmacology, 22, 98–101., [PUBMED], [INFOTRIEVE], [CSA]
  • Wasan, K. M. (1996). Modifications in plasma lipoprotein concentration and lipid composition regulated the biological activity of hydrophobic drugs. Journal of Pharmacological and Toxicological Methods, 36, 1–11., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wasan, K. M., & Cassidy, S. M. (1998). Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. Journal of Pharmaceutical Sciences, 87, 411–424., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Wasan, K. M., Vadiei, K., Lopez-Berestein, G., & Luke, D. R. (1990). Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. Journal of Infectious Diseases, 161, 562–566., [PUBMED], [INFOTRIEVE]
  • Wasan, K. M., Cassidy, S. M., Ramaswamy, M., Kennedy, A., Strobel, F. W., Ng, S. P., & Lee, T. Y. (1999). A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cycloporine. Pharmaceutical Research, 16, 165–169., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.